Lady Prelox® improves sexual function in post-menopausal women

Area of Science:

• Reproductive Medicine
• Nutritional Science
• Women's Health

Background:

• Menopause is associated with changes in sexual function.
• Dietary supplements are being explored for managing menopausal symptoms.
• Female sexual dysfunction (FSD) impacts quality of life.

Purpose of the Study:

• To evaluate the efficacy of Lady Prelox® in improving sexual function in post-menopausal women.
• To assess the impact of Lady Prelox® on the domains of the Female Sexual Function Index (FSFI).

Main Methods:

• Pilot, single-blinded study with two groups: Lady Prelox® (n=40) and placebo (n=43).
• Participants were generally healthy, post-menopausal women aged approximately 50 years.
• The Female Sexual Function Index (FSFI) was used to measure sexual function over an eight-week period.

Main Results:

• Lady Prelox® significantly increased total FSFI scores from baseline (44.6) to 70.9 at 4 weeks and 71.7 at 8 weeks.
• The placebo group showed non-significant increases in total FSFI scores (44.1 at baseline to 47.4 at 8 weeks).
• Lady Prelox® demonstrated significantly greater efficacy than placebo (P<0.05) across all six FSFI domains.

Conclusions:

• Lady Prelox® shows promise as a new treatment option for women with moderate sexual function impairment.
• Further research with larger cohorts, including premenopausal and perimenopausal women, is warranted.
• The supplement was well-tolerated with no reported adverse effects.